Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,219
Sort by:
Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global oncology molecular diagnostics market size reached USD 5.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.1 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
138 pages
Oncolytic Virus Therapies Market Report by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2026-2034
US$ 2,999.00
The global oncolytic virus therapies market size reached USD 222.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 815.4 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
138 pages
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres, and Others) 2026-2034
US$ 2,999.00
The Saudi Arabia in-vitro diagnostics (IVD) market size reached USD 785.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,095.6 Million by 2034, exhibiting a growth rat...
April 2026
135 pages
Blood Gas and Electrolyte Analyzer Market Report by Product Type (Analyzers, Consumables), Modality (Benchtop, Portable), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region 2026-2034
US$ 2,999.00
The global blood gas and electrolyte analyzer market size reached USD 2.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (C...
April 2026
137 pages
Histology and Cytology Market Report by Product (Instruments and Analysis Software System, Consumable and Reagents), Type of Examination (Histology, Cytology), Test Type (Microscopy Tests, Molecular Genetics Tests, Flow Cytometry), Application (Drug Discovery and Designing, Clinical Diagnostics, Research), and Region 2026-2034
US$ 2,999.00
The global histology and cytology market size reached USD 19.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 43.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8....
April 2026
146 pages
In-vitro Colorectal Cancer Screening Tests Market Size, Share, Trends and Forecast by Product, Imaging Type, End User, and Region, 2026-2034
US$ 2,999.00
The global in-vitro colorectal cancer screening tests market size was valued at USD 1,101.3 Million in 2025. The market is projected to reach USD 1,709.7 Million by 2034, exhibiting a CAGR of 4.76% fr...
April 2026
142 pages
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2026-2034
US$ 2,999.00
The global renal biomarkers market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.28% duri...
April 2026
139 pages
Blood Culture Test Market Size, Share, Trends and Forecast by Testing Method, Product, Technology, Application, End User, and Region, 2026-2034
US$ 2,999.00
The global blood culture test market size was valued at USD 5.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.0 Billion by 2034, exhibiting a CAGR of 6.91% from 20...
April 2026
149 pages
Cell Analysis Market Report by Product (Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, HCS Systems, and Others), Analysis Type (Cell Identification, Cell Viability, Cell Signaling Pathways/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Target Identification and Validation, Single-Cell Analysis, and Others), Techniques (Molecular Approaches, Image-Based Approaches), End-User (Pharmaceutical and Biotechnology Companies and CROs, Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, and Others), and Region 2026-2034
US$ 2,999.00
The global cell analysis market size reached USD 23.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 42.8 Billion by 2034, exhibiting a growth rate (CAGR) of 6.54% durin...
April 2026
145 pages
Clinical Microbiology Market Report by Product (Laboratory Instruments, Automated Culture Systems, Reagents), Application (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections (UTIs), Periodontal Diseases, and Others), End User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic and Research Institutes), and Region 2026-2034
US$ 2,999.00
The global clinical microbiology market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.18%...
April 2026
137 pages
Flow Cytometry Market Report by Product and Service (Instruments, Reagents and Consumables, Accessories, Software, Services), Technology (Cell-Based Flow Cytometry, Bead-Based Flow Cytometry), Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology, and Others), End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Region 2026-2034
US$ 2,999.00
The global flow cytometry market size reached USD 6.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 11.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.37% durin...
April 2026
141 pages
Gel Documentation Systems Market Report by Product Type (Instruments, Software, Accessories), Light Source (Light Emitting Diodes, UV, Laser), Detection Technique (UV Detectors, Fluorescence, Chemiluminescence), Application (Nucleic Acid Quantification, Protein Quantification, and Others), End User (Academic and Research Institutes, Pharma and Biotech Companies, Diagnostic Laboratories), and Region 2026-2034
US$ 2,999.00
The global gel documentation systems market size reached USD 343.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 446.9 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
135 pages
High-Performance Liquid Chromatography (HPLC) Market Report by Product (Instruments, Consumables, Accessories), Application (Clinical Research, Diagnostics, Forensic, and Others), and Region 2026-2034
US$ 2,999.00
The global high-performance liquid chromatography (HPLC) market size reached USD 6.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.6 Billion by 2034, exhibiting a gro...
April 2026
137 pages
HPV Testing and PAP Test Market Size, Share, Trends and Forecast by Test Type, Product, Application, End User, and Region, 2026-2034
US$ 2,999.00
The global HPV testing and Pap test market size was valued at USD 4.7 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 7.2 Billion by 2034, exhibiting a CAGR of 4.76% fr...
April 2026
141 pages
Liposomal Doxorubicin Market Report by Product (Doxil/Caelyx, Lipodox, Myocet, and Others), Application (Leukemia, Bone Sarcoma, Breast Cancer, Endometrial Cancer, Kidney Cancer, Multiple Myeloma, Kaposi Sarcoma, and Others), and Region 2026-2034
US$ 2,999.00
The global liposomal doxorubicin market size reached USD 1.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.53%...
April 2026
145 pages
Microtome Market Report by Product (Microtome Devices, Accessories), Technology (Fully Automated, Semi-Automated, Manual), End User (Hospital Laboratories, Clinical Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global microtome market size reached USD 182.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 260.4 Million by 2034, exhibiting a growth rate (CAGR) of 4.00% during...
April 2026
142 pages
Molecular Cytogenetics Market Report by Product Type (Instruments, Consumables, Software and Services, and Others), Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization (FISH), Immunohistochemistry, Karyotyping, and Others), Application (Genetic Disorders, Oncology, Personalized Medicine, and Others), End User (Clinical and Research Laboratories, Hospitals and Pathology Laboratories, Pharmaceutical and Biotechnology Companies, and Others), and Region 2026-2034
US$ 2,999.00
The global molecular cytogenetics market size reached USD 3.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.6 Billion by 2034, exhibiting a growth rate (CAGR) of 8.28...
April 2026
145 pages
Ovarian Cancer Market Report by Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), Treatment Type (Immunotherapy, Chemotherapy, Targeted Therapy, Surgery, and Others), End User (Hospitals, Homecare, Speciality Centre, and Others), and Region 2026-2034
US$ 2,999.00
The global ovarian cancer market size reached USD 2.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2034, exhibiting a growth rate (CAGR) of 9.21% during...
April 2026
139 pages
Drug Abuse Testing Market Report by Product (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), Sample (Urine, Oral Fluid (Saliva), Hair, Breath, and Others), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Workplaces, and Others), and Region 2026-2034
US$ 2,999.00
The global drug abuse testing market size reached USD 7.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.36% d...
April 2026
140 pages
Pyrogen Testing Market Report by Product (Instruments, Kits and Reagents, Services), Test Type (In-vitro Tests, LAL Tests, Rabbit Tests, and Others), Application (Pharmaceutical and Biologics, Medical Devices, and Others), and Region 2026-2034
US$ 2,999.00
The global pyrogen testing market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of 8.36% durin...
April 2026
139 pages
Tissue Banking Market Report by Product (Equipment, Media and Consumables), Application (Therapeutics, Medical Research, and Others), Tissue Type (Cardiovascular Tissue, Lung Tissue, Kidney Tissue, Pancreas Tissue, Liver Tissue, Eye Tissue, and Others), and Region 2026-2034
US$ 2,999.00
The global tissue banking market size reached USD 2.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2034, exhibiting a growth rate (CAGR) of 9.20% during...
April 2026
139 pages
Transplant Diagnostics Market Report Size, Share, Trends and Forecast by Component, Technology, Organ Type, Application, End User, and Region, 2026-2034
US$ 2,999.00
The global transplant diagnostics market size was valued at USD 1,006.3 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 1,859.5 Million by 2034, exhibiting a CAGR of 6....
April 2026
141 pages
Cancer/Tumor Profiling Market Size, Share, Trends, and Forecast by Cancer Type, Technology, Technique, Application, and Region, 2026-2034
US$ 2,999.00
The global cancer/tumor profiling market size was valued at USD 13.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 27.3 Billion by 2034, exhibiting a CAGR of 7.89% du...
April 2026
149 pages
GCC In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagent and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients, and Others), and Country 2026-2034
US$ 2,999.00
The GCC in vitro diagnostics market size reached USD 1,334.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,876.1 Million by 2034, exhibiting a growth rate (CAGR) of 3...
April 2026
144 pages
In-Vitro Diagnostic Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), End User (Hospitals, Laboratories, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)
US$ 4,450.00
The In-Vitro Diagnostics market is anticipated to grow from US$ 112.04 Billion in 2025 to US$ 218.73 Billion by 2034; the market is expected to register a CAGR of 7.8% from 2026 to 2034. In-Vitro Diag...
April 2026
924 pages
Activated Clotting Time Testing Market Size, Share & Trends Analysis Report By Product (ACT Analyzers, Consumables), By Test Type, By Application (Cardiovascular Surgery, Interventional Cardiology, Hemodialysis), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global activated clotting time testing market size was estimated at USD 1.19 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The gr...
March 2026
120 pages
HDL Cholesterol Kits Market - 2026-2033
US$ 3,400.00
HDL Cholesterol Kits Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The HDL Cholesterol Kits Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
March 2026
46 pages
Channel Coagulometer Market - 2026-2033
US$ 3,400.00
The Channel Coagulometer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
March 2026
46 pages
Cryostat Microbiome Equipment Market - 2026-2033
US$ 3,400.00
Cryostat Microbiome Equipment Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Cryostat Microbiome Equipment Market emerges as a key focus in DataM Intelligence lates...
March 2026
55 pages
Tissue Diagnostics Market - 2026-2033
US$ 3,400.00
Tissue Diagnostics Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Tissue Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
March 2026
44 pages
Human Identification Market by Product [Consumables (Kits & Reagents), Instruments, Software], Technology (PCR, Capillary Electrophoresis, NGS, Microarray, Rapid DNA Analysis), Application (Forensics, Paternity Testing), End User - Global Forecast to 2031
US$ 2,970.00
... Inc. (US). Research Coverage: The report analyses the human identification market by product & service, technology, application, end user, and ... and business segments of the leading players in the human identification market Product Development/Innovation: Detailed insights on the upcoming technologies, ...
March 2026
345 pages
Microsampling & Minimally Invasive Blood Collection Market Size, Share & Trends Analysis Report By Product (Microsampling Devices, DBS Collection Devices, At-Home Blood Collection Devices), By Application, By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global microsampling & minimally invasive blood collection market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 8.15% from...
March 2026
120 pages
Live Cell Imaging Market - 2026-2033
US$ 3,400.00
Live Cell Imaging Market reached US$ 3.12 Billion in 2025 and is expected to reach US$ 6.13 Billion by 2033, growing with a CAGR of 8.80% during the forecast period 2026-2033. The Live Cell Imaging Ma...
March 2026
43 pages
Sterility Testing Market - 2026-2033
US$ 3,400.00
Sterility Testing Market reached USD 1,484.0 million in 2025 and is expected to reach USD 3,743.2 million by 2033, growing with a CAGR of 12.22% during the forecast period 2026-2033. The Sterility Tes...
March 2026
43 pages
Minimal Residual Disease (MRD) Liquid Biopsy Market Forecasts to 2034 – Global Analysis By Product (NGS-Based MRD Assays, PCR-Based MRD Assays, Digital PCR MRD Tests, Cell-Free DNA MRD Tests, Other Products), By Cancer Type, By Sample Type, By Technology, By End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Minimal Residual Disease (MRD) Liquid Biopsy Market is accounted for $1.9 billion in 2026 and is expected to reach $4.7 billion by 2034 growing at a CAGR of 12...
March 2026
200 pages
Asia Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Asia Pacific donor blood component market is projected to grow significantly, reaching an estimated US$ 1,878.3 million by 2031, up from US$ 1,262.3 million in 2024, reflecting a compound annual g...
March 2026
189 pages
Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Europe Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 3,464.5 million by 2031, up from US$ 2,420.0 million in 2024, reflecting a compound annual growth...
March 2026
170 pages
Middle East & Africa Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Middle East & Africa Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 525.2 million by 2031, up from US$ 384.6 million in 2024. This growth represents a c...
March 2026
180 pages
North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The North America donor blood component market is projected to grow significantly, reaching an estimated US$ 8,048.4 million by 2031, up from US$ 5,482.7 million in 2024, reflecting a compound annual...
March 2026
176 pages
South & Central America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The South & Central America Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 730.3 million by 2031, up from US$ 533.2 million in 2024. This growth reflects a...
March 2026
178 pages
